{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:43Z","timestamp":1777870423051,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40620-015-0193-1","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T07:13:25Z","timestamp":1428563605000},"page":"679-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease"],"prefix":"10.1093","volume":"28","author":[{"given":"Martina","family":"Gaggl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Kleinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Fauler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kotanko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Paschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"193_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.6836295","volume":"220","author":"E Nudelman","year":"1983","unstructured":"Nudelman E, Kannagi R, Hakomori S, Parsons M, Lipinski M, Wiels J, Fellous M, Tursz T (1983) A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220:509\u2013511","journal-title":"Science"},{"key":"193_CR2","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.1016\/S0021-9258(19)86468-2","volume":"254","author":"KS Fletcher","year":"1979","unstructured":"Fletcher KS, Bremer EG, Schwarting GA (1979) P blood group regulation of glycosphingolipid levels in human erythrocytes. J Biol Chem 254:11196\u201311198","journal-title":"J Biol Chem"},{"key":"193_CR3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-291X(88)80091-3","volume":"152","author":"T Waddell","year":"1988","unstructured":"Waddell T, Head S, Petric M, Cohen A, Lingwood C (1988) Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun 152:674\u2013679 (pii: S0006-291X(88)80091-3)","journal-title":"Biochem Biophys Res Commun"},{"key":"193_CR4","first-page":"303","volume":"11","author":"CA Lingwood","year":"2011","unstructured":"Lingwood CA, Branch DR (2011) The role of glycosphingolipids in HIV\/AIDS. Discov Med 11:303\u2013313","journal-title":"Discov Med"},{"key":"193_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1373\/clinchem.2004.041418","volume":"51","author":"M Fuller","year":"2005","unstructured":"Fuller M, Sharp PC, Rozaklis T, Whitfield PD, Blacklock D, Hopwood JJ, Meikle PJ (2005) Urinary lipid profiling for the identification of fabry hemizygotes and heterozygotes. Clin Chem 51:688\u2013694. doi: 10.1373\/clinchem.2004.041418","journal-title":"Clin Chem"},{"key":"193_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-005-5263-4","volume":"28","author":"K Mills","year":"2005","unstructured":"Mills K, Morris P, Lee P, Vellodi A, Waldek S, Young E, Winchester B (2005) Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease. J Inherit Metab Dis 28:35\u201348. doi: 10.1007\/s10545-005-5263-4","journal-title":"J Inherit Metab Dis"},{"key":"193_CR7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.ajkd.2010.10.046","volume":"57","author":"E Paschke","year":"2011","unstructured":"Paschke E, Fauler G, Winkler H, Schlagenhauf A, Plecko B, Erwa W, Breunig F, Urban W, Vujkovac B, Sunder-Plassmann G, Kotanko P (2011) Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study. Am J Kidney Dis 57:673\u2013681. doi: 10.1053\/j.ajkd.2010.10.046","journal-title":"Am J Kidney Dis"},{"key":"193_CR8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/rcm.1948","volume":"19","author":"G Fauler","year":"2005","unstructured":"Fauler G, Rechberger GN, Devrnja D, Erwa W, Plecko B, Kotanko P, Breunig F, Paschke E (2005) Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standard. Rapid Commun Mass Spectrom 19:1499\u20131506. doi: 10.1002\/rcm.1948","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"Suppl 1","key":"193_CR9","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1073\/pnas.1001501107","volume":"108","author":"D An","year":"2011","unstructured":"An D, Na C, Bielawski J, Hannun YA, Kasper DL (2011) Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci USA 108(Suppl 1):4666\u20134671. doi: 10.1073\/pnas.1001501107","journal-title":"Proc Natl Acad Sci USA"},{"key":"193_CR10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtl\u00e4nder T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, Hauser AC, Kofler HJ, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, F\u00f6dinger M, Sunder-Plassmann G (2004) Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 15:1323\u20131329. doi: 10.1097\/01.ASN.0000124671.61963.1E","journal-title":"J Am Soc Nephrol"},{"key":"193_CR11","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812\u20132817. doi: 10.1073\/pnas.0712309105","journal-title":"Proc Natl Acad Sci USA"},{"key":"193_CR12","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","volume":"411","author":"C Auray-Blais","year":"2012","unstructured":"Auray-Blais C, Ntwari A, Clarke JT, Warnock DG, Oliveira JP, Young SP, Millington DS, Bichet DG, Sirrs S, West ML, Casey R, Hwu WL, Keutzer JM, Zhang XK, Gagnon R (2012) How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? Clin Chim Acta 411:1906\u20131914. doi: 10.1016\/j.cca.2010.07.038","journal-title":"Clin Chim Acta"},{"key":"193_CR13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","volume":"1802","author":"SM Rombach","year":"2010","unstructured":"Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, Kuiper S, Vd Bergh Weerman MA, Groener JE, Poorthuis BJ, Hollak CE, Aerts JM (2010) Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta 1802:741\u2013748. doi: 10.1016\/j.bbadis.2010.05.003","journal-title":"Biochim Biophys Acta"},{"key":"193_CR14","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","volume":"84","author":"C Auray-Blais","year":"2012","unstructured":"Auray-Blais C, Boutin M, Gagnon R, Dupont FO, Lavoie P, Clarke JT (2012) Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics. Anal Chem 84:2745\u20132753. doi: 10.1021\/ac203433e","journal-title":"Anal Chem"},{"key":"193_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-2275(20)43219-5","volume":"31","author":"I Hozumi","year":"1990","unstructured":"Hozumi I, Nishizawa M, Ariga T, Miyatake T (1990) Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry\u2019s disease) in comparison with hemizygotes. J Lipid Res 31:335\u2013340","journal-title":"J Lipid Res"},{"key":"193_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2215\/CJN.06090809","volume":"5","author":"R Schiffmann","year":"2010","unstructured":"Schiffmann R, Waldek S, Benigni A, Auray-Blais C (2010) Biomarkers of Fabry disease nephropathy. Clin J Am Soc Nephrol 5:360\u2013364. doi: 10.2215\/CJN.06090809","journal-title":"Clin J Am Soc Nephrol"},{"key":"193_CR17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-2275(20)38884-2","volume":"8","author":"DE Vance","year":"1967","unstructured":"Vance DE, Sweeley CC (1967) Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res 8:621\u2013630","journal-title":"J Lipid Res"},{"key":"193_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08035320510028111","volume":"94","author":"E Young","year":"2005","unstructured":"Young E, Mills K, Morris P, Vellodi A, Lee P, Waldek S, Winchester B (2005) Is globotriaosylceramide a useful biomarker in Fabry disease? Acta Paediatr Suppl 94:51\u201354 (discussion 37\u201358)","journal-title":"Acta Paediatr Suppl"},{"key":"193_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-5793(02)02491-2","volume":"515","author":"K Mills","year":"2002","unstructured":"Mills K, Johnson A, Winchester B (2002) Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry. FEBS Lett 515:171\u2013176 (pii: S0014579302024912)","journal-title":"FEBS Lett"},{"key":"193_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-2275(20)36996-0","volume":"17","author":"G Dawson","year":"1976","unstructured":"Dawson G, Kruski AW, Scanu AM (1976) Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J Lipid Res 17:125\u2013131","journal-title":"J Lipid Res"},{"key":"193_CR21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","volume":"30","author":"AC Vedder","year":"2007","unstructured":"Vedder AC, Linthorst GE, van Breemen MJ, Groener JE, Bemelman FJ, Strijland A, Mannens MM, Aerts JM, Hollak CE (2007) The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels. J Inherit Metab Dis 30:68\u201378. doi: 10.1007\/s10545-006-0484-8","journal-title":"J Inherit Metab Dis"},{"key":"193_CR22","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1194\/jlr.M017178","volume":"52","author":"B Durant","year":"2011","unstructured":"Durant B, Forni S, Sweetman L, Brignol N, Meng XL, Benjamin ER, Schiffmann R, Shen JS (2011) Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice. J Lipid Res 52:1742\u20131746. doi: 10.1194\/jlr.M017178","journal-title":"J Lipid Res"},{"key":"193_CR23","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1016\/S0021-9258(18)43014-1","volume":"256","author":"RH McCluer","year":"1981","unstructured":"McCluer RH, Williams MA, Gross SK, Meisler MH (1981) Testosterone effects on the induction and urinary excretion of mouse kidney glycosphingolipids associated with lysosomes. J Biol Chem 256:13112\u201313120","journal-title":"J Biol Chem"},{"key":"193_CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1291\/hypres.21.279","volume":"21","author":"H Koshida","year":"1998","unstructured":"Koshida H, Takeda R, Miyamori I (1998) Lisinopril decreases plasma free testosterone in male hypertensive patients and increases sex hormone binding globulin in female hypertensive patients. Hypertens Res 21:279\u2013282","journal-title":"Hypertens Res"},{"key":"193_CR25","doi-asserted-by":"crossref","first-page":"e000394","DOI":"10.1161\/JAHA.113.000394","volume":"3","author":"R Schiffmann","year":"2014","unstructured":"Schiffmann R, Forni S, Swift C, Brignol N, Wu X, Lockhart DJ, Blankenship D, Wang X, Grayburn PA, Taylor MR, Lowes BD, Fuller M, Benjamin ER, Sweetman L (2014) Risk of death in heart disease is associated with elevated urinary globotriaosylceramide. J Am Heart Assoc 3:e000394. doi: 10.1161\/JAHA.113.000394","journal-title":"J Am Heart Assoc"},{"key":"193_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cca.2013.06.027","volume":"425","author":"L Kuchar","year":"2013","unstructured":"Kuchar L, Asfaw B, Poupetova H, Honzikova J, Turecek F, Ledvinova J (2013) Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy. Clin Chim Acta 425:153\u2013159. doi: 10.1016\/j.cca.2013.06.027","journal-title":"Clin Chim Acta"},{"key":"193_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2009.01.011","volume":"97","author":"S Forni","year":"2009","unstructured":"Forni S, Fu X, Schiffmann R, Sweetman L (2009) Falsely elevated urinary Gb3 (globotriaosylceramide, CTH, GL3). Mol Genet Metab 97:91. doi: 10.1016\/j.ymgme.2009.01.011","journal-title":"Mol Genet Metab"},{"key":"193_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2009.04.006","volume":"97","author":"C Auray-Blais","year":"2009","unstructured":"Auray-Blais C, Millington DS, Barr C, Young SP, Mills K, Clarke JT (2009) Gb(3)\/creatinine biomarkers for Fabry disease: issues to consider. Mol Genet Metab 97:237. doi: 10.1016\/j.ymgme.2009.04.006","journal-title":"Mol Genet Metab"},{"key":"193_CR29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/WNL.32.10.1139","volume":"32","author":"WJ Cable","year":"1982","unstructured":"Cable WJ, McCluer RH, Kolodny EH, Ullman MD (1982) Fabry disease: detection of heterozygotes by examination of glycolipids in urinary sediment. Neurology 32:1139\u20131145","journal-title":"Neurology"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-015-0193-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0193-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:22Z","timestamp":1777564702000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/6\/679\/8372345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1007\/s40620-015-0193-1","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}